A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Pfizer
Pfizer
Kivu Bioscience Inc.
Boehringer Ingelheim
ViroMissile, Inc.
Erasca, Inc.
Dana-Farber Cancer Institute
Eli Lilly and Company
Poseida Therapeutics, Inc.
MacroGenics
Boehringer Ingelheim
City of Hope Medical Center
SN BioScience
Eli Lilly and Company
University of Southern California
AbbVie
Actym Therapeutics, Inc.
Ikena Oncology
Memgen, Inc.
Bicara Therapeutics
Jonsson Comprehensive Cancer Center
Sichuan Enray Pharmaceutical Sciences Company
DEKA Biosciences
Pfizer
Columbia University
Carisma Therapeutics Inc
Acepodia Biotech, Inc.
Astellas Pharma Inc
NGM Biopharmaceuticals, Inc
NantBioScience, Inc.
Suzhou Genhouse Bio Co., Ltd.
Xencor, Inc.
NGM Biopharmaceuticals, Inc
Celldex Therapeutics
Ikena Oncology
Corvus Pharmaceuticals, Inc.
Emory University
Fate Therapeutics
Tempest Therapeutics
Fate Therapeutics
Xencor, Inc.
Quadriga Biosciences, Inc.
Genzada Pharmaceuticals USA, Inc.
Wellmarker Bio
Incyte Corporation
Five Prime Therapeutics, Inc.
MacroGenics
MacroGenics
Weill Medical College of Cornell University
Tocagen Inc.
Ipsen